Molecular regulation of macrophage reverse cholesterol transport

Glomset, 1968, The plasma lecithin:cholesterol acyltransferase reaction, J Lipid Res, 9, 155, 10.1016/S0022-2275(20)43114-1

Bortnick, 2000, The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines, J Biol Chem, 275, 28634, 10.1074/jbc.M003407200

Wang, 2004, ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins, Proc Natl Acad Sci U S A, 101, 9774, 10.1073/pnas.0403506101

Kennedy, 2005, ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation, Cell Metab, 1, 121, 10.1016/j.cmet.2005.01.002

Schwartz, 2000, ABC1 gene expression and apoA-I-mediated cholesterol efflux are regulated by LXR, Biochem Biophys Res Commun, 274, 794, 10.1006/bbrc.2000.3243

Costet, 2000, Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor, J Biol Chem, 275, 28240, 10.1074/jbc.M003337200

Rust, 1999, Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1, Nat Genet, 22, 352, 10.1038/11921

Bodzioch, 1999, The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease, Nat Genet, 22, 347, 10.1038/11914

Brooks-Wilson, 1999, Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency, Nat Genet, 22, 336, 10.1038/11905

Haghpassand, 2001, Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels, J Clin Invest, 108, 1315, 10.1172/JCI200112810

Van Eck, 2002, Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues, Proc Natl Acad Sci U S A, 99, 6298, 10.1073/pnas.092327399

Van Eck, 2006, Macrophage ATP-binding cassette transporter A1 overexpression inhibits atherosclerotic lesion progression in low-density lipoprotein receptor knockout mice, Arterioscler Thromb Vasc Biol, 26, 929, 10.1161/01.ATV.0000208364.22732.16

Wang, 2006, LXR-induced redistribution of ABCG1 to plasma membrane in macrophages enhances cholesterol mass efflux to HDL, Arterioscler Thromb Vasc Biol, 26, 1310, 10.1161/01.ATV.0000218998.75963.02

Gelissen, 2006, ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I, Arterioscler Thromb Vasc Biol, 26, 534, 10.1161/01.ATV.0000200082.58536.e1

Matsuura, 2006, HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway, J Clin Invest, 116, 1435, 10.1172/JCI27602

Joyce, 2006, ABCA1 overexpression in the liver of LDLr-KO mice leads to accumulation of pro-atherogenic lipoproteins and enhanced atherosclerosis, J Biol Chem, 281, 33053, 10.1074/jbc.M604526200

Wang, 2007, Different intracellular trafficking of LDL- and acetylated LDL-derived cholesterol lead to distinct reverse cholesterol transport mechanisms, J Lipid Res, 48, 633, 10.1194/jlr.M600470-JLR200

Out, 2006, Macrophage ABCG1 deletion disrupts lipid homeostasis in alveolar macrophages and moderately influences atherosclerotic lesion development in LDL receptor-deficient mice, Arterioscler Thromb Vasc Biol, 26, 2295, 10.1161/01.ATV.0000237629.29842.4c

Out, 2007, Total body ABCG1 expression protects against early atherosclerotic lesion development in mice, Arterioscler Thromb Vasc Biol, 27, 594, 10.1161/01.ATV.0000257136.24308.0c

Baldan, 2006, Impaired development of atherosclerosis in hyperlipidemic Ldlr–/– and ApoE–/– mice transplanted with Abcg1–/– bone marrow, Arterioscler Thromb Vasc Biol, 26, 2301, 10.1161/01.ATV.0000240051.22944.dc

Ranalletta, 2006, Decreased atherosclerosis in low-density lipoprotein receptor knockout mice transplanted with Abcg1–/– bone marrow, Arterioscler Thromb Vasc Biol, 26, 2308, 10.1161/01.ATV.0000242275.92915.43

Curtiss, 2006, Is two out of three enough for ABCG1?, Arterioscler Thromb Vasc Biol, 26, 2175, 10.1161/01.ATV.0000243741.89303.27

Chinetti, 2000, CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors, Circulation, 101, 2411, 10.1161/01.CIR.101.20.2411

Ji, 1997, Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux, J Biol Chem, 272, 20982, 10.1074/jbc.272.34.20982

Zhang, 2003, Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice, Circulation, 108, 2258, 10.1161/01.CIR.0000093189.97429.9D

Brundert, 2006, Selective uptake of HDL cholesteryl esters and cholesterol efflux from mouse peritoneal macrophages independent of SR-BI, J Lipid Res, 47, 2408, 10.1194/jlr.M600136-JLR200

Rader, 2006, Molecular regulation of HDL metabolism and function: implications for novel therapies, J Clin Invest, 116, 3090, 10.1172/JCI30163

Hoeg, 1996, Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis, Proc Natl Acad Sci U S A, 93, 11448, 10.1073/pnas.93.21.11448

Hoeg, 1996, Lecithin:cholesterol acyltransferase overexpression generates hyperalpha-lipoproteinemia and a nonatherogenic lipoprotein pattern in transgenic rabbits, J Biol Chem, 271, 4396, 10.1074/jbc.271.8.4396

Mehlum, 1997, Mice overexpressing human lecithin: cholesterol acyltransferase are not protected against diet-induced atherosclerosis, Apmis, 105, 861, 10.1111/j.1699-0463.1997.tb05095.x

Berard, 1997, High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin:cholesteryl acyltransferase, Nat Med, 3, 744, 10.1038/nm0797-744

Foger, 1999, Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice, J Biol Chem, 274, 36912, 10.1074/jbc.274.52.36912

Rigotti, 1997, A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism, Proc Natl Acad Sci U S A, 94, 12610, 10.1073/pnas.94.23.12610

Wang, 1998, Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice, J Biol Chem, 273, 32920, 10.1074/jbc.273.49.32920

Kozarsky, 1997, Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels, Nature, 387, 414, 10.1038/387414a0

Zhang, 2005, Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo, J Clin Invest, 115, 2870, 10.1172/JCI25327

Zhang, 2001, Expression of cholesteryl ester transfer protein in human atherosclerotic lesions and its implication in reverse cholesterol transport, Atherosclerosis, 159, 67, 10.1016/S0021-9150(01)00490-7

Inazu, 1990, Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation, N Engl J Med, 323, 1234, 10.1056/NEJM199011013231803

Hayek, 1992, An interaction between the human cholesteryl ester transfer protein (CETP) and apolipoprotein A-I genes in transgenic mice results in a profound CETP-mediated depression of high density lipoprotein cholesterol levels, J Clin Invest, 90, 505, 10.1172/JCI115887

Okamoto, 2000, A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits, Nature, 406, 203, 10.1038/35018119

Plump, 1999, Increased atherosclerosis in ApoE and LDL receptor gene knock-out mice as a result of human cholesteryl ester transfer protein transgene expression, Arterioscler Thromb Vasc Biol, 19, 1105, 10.1161/01.ATV.19.4.1105

Hayek, 1995, Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene, J Clin Invest, 96, 2071, 10.1172/JCI118255

Brousseau, 2004, Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol, N Engl J Med, 350, 1505, 10.1056/NEJMoa031766

Tall, 2007, The failure of torcetrapib: was it the molecule or the mechanism?, Arterioscler Thromb Vasc Biol, 27, 257, 10.1161/01.ATV.0000256728.60226.77

Brunham, 2006, Intestinal ABCA1 directly contributes to HDL biogenesis in vivo, J Clin Invest, 116, 1052, 10.1172/JCI27352

Nissen, 2007, Effect of torcetrapib on the progression of coronary atherosclerosis, N Engl J Med, 356, 1304, 10.1056/NEJMoa070635

Kastelein, 2007, Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia, N Engl J Med, 356, 1620, 10.1056/NEJMoa071359

Schwartz, 2004, Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans, J Lipid Res, 45, 1594, 10.1194/jlr.M300511-JLR200

Zhang, 2003, Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo, Circulation, 108, 661, 10.1161/01.CIR.0000086981.09834.E0

Nissen, 2003, Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial, JAMA, 290, 2292, 10.1001/jama.290.17.2292

Joseph, 2002, Synthetic LXR ligand inhibits the development of atherosclerosis in mice, Proc Natl Acad Sci U S A, 99, 7604, 10.1073/pnas.112059299

Claudel, 2001, Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor, Proc Natl Acad Sci U S A, 98, 2610, 10.1073/pnas.041609298

Naik, 2006, Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo, Circulation, 113, 90, 10.1161/CIRCULATIONAHA.105.560177

Tontonoz, 2003, Liver X receptor signaling pathways in cardiovascular disease, Mol Endocrinol, 17, 985, 10.1210/me.2003-0061

Chinetti, 2001, PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway, Nat Med, 7, 53, 10.1038/83348

Chawla, 2001, A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis, Mol Cell, 7, 161, 10.1016/S1097-2765(01)00164-2

Oliver, 2001, A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport, Proc Natl Acad Sci U S A, 98, 5306, 10.1073/pnas.091021198

Vu-Dac, 1998, The nuclear receptors peroxisome proliferator-activated receptor alpha and Rev-erbalpha mediate the species-specific regulation of apolipoprotein A-I expression by fibrates, J Biol Chem, 273, 25713, 10.1074/jbc.273.40.25713

Li, 2004, Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma, J Clin Invest, 114, 1564, 10.1172/JCI18730

Kontush, 2006, Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis, Pharmacol Rev, 58, 342, 10.1124/pr.58.3.1

Rubic, 2004, Stimulation of CD36 and the key effector of reverse cholesterol transport ATP-binding cassette A1 in monocytoid cells by niacin, Biochem Pharmacol, 67, 411, 10.1016/j.bcp.2003.09.014